Filing Details
- Accession Number:
- 0000899243-21-025735
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-24 16:15:31
- Reporting Period:
- 2021-06-22
- Accepted Time:
- 2021-06-24 16:15:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1840904 | Atai Life Sciences N.v. | ATAI | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1746080 | Michael Auerbach | C/O Subversive Atai Llc 217 Centre Street, Suite 122 New York NY 10013 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares | Acquisiton | 2021-06-22 | 4,666 | $15.00 | 5,564,474 | No | 4 | P | Indirect | By Subversive Atai LLC |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Subversive Atai LLC |
Footnotes
- Mr. Auerbach serves as General Partner of Subversive ATAI LLC, a multi-member limited liability company. Mr. Auerbach has sole voting and investment power with respect to the shares held by Subversive ATAI LLC.